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Exposure of Human Proximal Tubule Cells to Cd2+, Zn2+, and Cu2+ Induces
Metallothionein Protein Accumulation but not Metallothionein
Isoform 2 mRNA
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Robert C. Byrd Health Sciences Center, Department of Pathology, West Virginia University, Morgantown, WV 26506
The oranization ofthe human meallothionein (MT) gene family is more complex than the
commonly used mouse and rat models. Thehuman MTs are encoded byafamilyofgenes con-
sisting of 10 functional and 7 nonfunctional MT isoforms. One objective ofthis study was to
determine ifthe accumulation ofMTprotein in culue ofhuman proximal tubule (HPI) cells
exosed to metals is similar to that expected from the knowledge base obtained from rodent
models. To accomplish thisobjective, HIT cells were exposed to both lethal and sublethal con-
centrations ofCd2, Zn2*, Cu2+ Ag2t Hg2, and Pb2+ and MT ptein l weredetermined
The results were in general ment th animal modal suiehre were some
:exceptions, mainly in areas w the model database was l Inlr aeement
withanimal models, Cd2, 7.2, a C2 were demonstted t b pot idcs ofMTpro-
tein accumulation. In contrastto aity in MT proteinexpression, w eo evidence
that the human renal MT-2 gene.hs a unique pattern ofrlation cmred to both animal
models and human-derived ceil cultures..In the present study, we determined that MT-2A
mRNAwas notinduced byexposure ofHPT cells to Cd2 ortheother metals, afindingin con-
tratto studies inbothanimal models andotherhuman celculturesystems inwhich ahighlevel
ofMT-2 mRNAinduction occurs uponeposuretoCt orZn2+. WhileMTprotein pression
may be similar betwee humans and animal modals, this finding provides initial evidence that
regulation ofthe genes underlying MT protein expression may be dierent beteen species.
Key words cadmium, copper, gene regulation, lead, mercury, metaiothionein, mRNA expres-
sion, nephtoity proximatuble, silver, zinc. Envron Health Pm :587-595 (1998).
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The metallothioneins (MTs) are a family of
low molecular weight, cysteine-rich intracel-
lular proteins that bind transition metals,
induding Cu2+, Zn2+, Ag2+, Hg2+, and CdP
(1). MTs have been shown in numerous ani-
mal and human tissues and derived cell lines
to behighly inducible bythese metals and by
a variety ofother chemicals and stimuli (2).
MTs have been proposed to play a role in
metal detoxification (Cd2+, Hg2+, Ag+, and
Pb2+), in essential metal homeostasis (Zn2+
and Cu2+), and in the protection of cells
against damage induced byalkylating agents,
oxygen radicals, and ionizing radiation (3).
Of particular importance is the role MTs
may play in mediating the adverse effects of
the heavy metal pollutant CdP. As summa-
rized by Misra et al. (4), the particular target
site sensitive to the toxic and carcinogenic
effects of cadmium often depends on the
species, strain, age, or sex ofthe animal used
as a test subject. Furthermore, there is evi-
dence that these differences in susceptibility
to the adverse effects ofCd> may be related,
at least in part, to the expression patterns of
the MTs. Oberdorster et al. (5) demonstrat-
ed that expression ofthe MTs may mediate
the species-specific susceptibility to Cd>_
induced pulmonary carcinogenesis in
rodents. Deficiencies in MT expression have
been implicated in susceptibility to Cd>
carcinogenesis in mammalian testes (6-8)
and the rat ventral prostate (9,10Q. While
the basis for the majority of species- and
strain-related differences in Cd2+ carcino-
genicity and toxicity remains undefined in
animals, the above studies provide evidence
suggesting that deficiencies in MT gene
expression may also underlie susceptibilities
in thehuman.
Knowledge regarding the regulation of
MT gene expression is even more limited
in humans than in rodent models. This is
partly due to the fact that the organization
of the human MT gene family is more
complex. In both mice and humans, there
are four classes of MT genes, designated
MT-1 through 4, based on sequence and
charge characteristics. In the mouse, the
genes encoding the MT-1 and MT-2 iso-
forms are both single copy genes and were
the only known rodent MT genes prior to
1992. They are located approximately 6 kb
apart on mouse chromosome 8, are coordi-
nately regulated, and the proteins are
thought to be functionally equivalent
(11,12). Two additional single-gene mem-
bers of the MT gene family have recently
been identified and designated as MT-3
and MT-4; these are closely linked to, but
not coordinately regulated with, the other
MT genes on mouse chromosome 8
(13,14). The mouse has no known MT
pseudogene sequences as determined by
Southern analysis. In contrast, the human
MTs are encoded by a family ofgenes con-
sisting of 10 functional (MT-lA, MT-1B,
MT-1E, MT-IF, MT-1G, MT-1H, MT-
IX, MT-2A, MT-3, MT-4) and 6 nonfunc-
tional MT isoforms (MT-IC, MT-iD,
MT-1I, MT-1J, MT-1K, MT-iL) located
at 16q13, plus an additional processed
pseudogene (MT-2B) located on chromo-
some 4 (13-16).
To address the possible alterations in
MT gene regulation in humans, we began
an analysis ofthe metal-induced expression
of the MT gene family in cultures of
human proximal tubule (HPT) cells. We
chose this cell culture system because the
kidney, and the proximal tubule in particu-
lar, represent an organ and cell type that are
critically affected by chronic Cd2+ exposure
in both animals and humans (17-21). In
the present report, the expression of MT
protein and MT-2A mRNA is determined
as afunction ofmetal exposure and cell tox-
icity in cultured HPT cells. The MT-2A
gene was chosen for initial examination
because it appears to be expressed ubiqui-
tously and induced by metals in awide vari-
etyofcells and tissues (22).
Materials and Methods
Cell culture. Stock cultures of HPT cells
were grown in 75-cm2 T-flasks using proce-
dures recently detailed by this laboratory
(23). The growth medium was a serum-free
formulation, and the growth surface was
treated with a collagen matrix to promote
cell attachment and subculture. The cells
were fed fresh growth medium every 3 days
and were subcultured at confluence (nor-
mally 3-6 days post subculture) using
trypsin (0.05%)-EDTA (0.02%). For use in
experimental protocols, cells were subcul-
tured at a 1:2 ratio, allowed to reach conflu-
ence (6 days following subculture), and
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exposed to medium containing the various
concentrations ofmetals. HepG2 and Hela
cells were obtained from the American
Type Culture Collection (Manassis, VA)
and grown according to instructions.
Preliminary experiments were per-
formed to determine the approximate con-
centrations ofmetal salts resulting in HPT
cell toxicity over a 16-day period ofexpo-
sure. Three concentrations of each metal
were chosen so that over a 16-day time
course at least one concentration would
result in appreciable cell death. These con-
centrations were 9, 27, and 45 PM for
Cd2+; 20, 40, and 60 pM for Hg2+; 50,
100, 150 pM for Ag2+; 50, 100, and 200
pM for Pb2+; 100, 200, and 300 PM for
Zn2+; and, 250, 500, and 750 pM for
Cu2+. Confluent HPT cells were treated
with these metal concentrations and cell
viability, MT protein, and MT-2A mRNA
were determined at days 1, 4, 7, 10, 13,
and 16 after metal exposure. In all
instances the cells were fed every 3 days
with media containing the appropriate
concentration of metal. Three isolates of
HPT cells were used to control for possible
variations in metal susceptibility. These
isolates were derived from normal cortical
tissue obtained from kidneys removed for
renal cell carcinoma. The kidneys were
from a 72-year-old white female, a 63-year-
old white male, and a 58-year-old white
female. At least 35 primary cell cultures
(75-cm2 flasks) were obtained from each
isolate and each had a culture lifespan ofat
least 17 passages at a 1:2 subculture ratio.
All cultures displayed senescence by subcul-
ture 25. HPT cells between passages 5 and
8 were used in the present study.
All experiments were performed in trip-
licate. Statistical analysis was performed
using SYSTAT software (Systat, Inc.,
Evanston, IL). Standard statistical tests
included determining the mean and stan-
dard error of the mean. When multiple
groups were compared, ANOVAwas used to
assess differences between groups using the
Tukey HSD (honestly significance differ-
ence) test. Unless otherwise stated, differences
were consideredsignificantwhen a = 0.050.
Cellviability. The effect ofmetal treat-
ment on the viability of confluent cell
monolayers was determined by the auto-
mated counting of 4',6-diamidino-2-
phenylindole (DAPI)-stained nuclei ofcells
fixed and processed at days 1, 4, 7, 10, 13,
and 16 of metal exposure. In this proce-
dure, we used the nuclear stain DAPI and
Kontron KS 400 image analysis software
(Kontron Elektronik, Newport Beach, CA)
as described previously (24). At the indicat-
ed time points, wells containing the mono-
layers were rinsed with phosphate-buffered
saline (PBS), fixed for 15 min in 70%
ethanol, rehydrated with PBS, and stained
with 10 pl DAPI (10 pg/ml in distilled
water). Foranalysis, eachwellwas examined
under epifluorescent illumination at 40x
magnification on a Zeiss Axiovert 35 (Carl
Zeiss Inc., Thornwood, NY) linked to the
computer with an Optronics DEI 470
CCD camera (Optronics, Goleta, CA). For
each time point, a minimum of 20 fields
per well and three wells per data point were
determined. Both nuclear counts and total
nuclear area were obtained from the pro-
gram andyielded equivalent results.
RNA isolation and reverse transcriptase-
polymerase chain reaction (RT-PCR). Total
RNA was isolated according to the protocol
supplied with TRI REAGENT (Molecular
Research Center, Inc., Cincinnati, OH) as
described previously (25). Wedetermined the
concentration andpurityofthe RNAsamples
using spectrophotometer scan in the UV
region and ethidium bromide (EtBr) visual-
ization ofintact 18S and28S RNAbandsfol-
lowing agarose gel electrophoresis. Total
RNA (0.1 pg) was reverse transcribed using
murine leukemia virus reverse transcriptase
(50 units) in IX PCR buffer (50 mM KCI
and 10 mM Tris-HCI, pH 8.3), 5 mM
MgCl2 solution, 20 units RNase inhibitor, 1
mM each ofthe dNTPs, and 2.5 mM ran-
dom hexanucleotide primers. The samples
were reverse transcribed for 20 min at 42°C,
followed by a 5 min denaturation step at
99C using a DNA thermocycler (Perkin-
Elmer-Cetus 9600; Perkin-Elmer, Foster
City, CA). The reverse transcribed product
was then used for PCR amplification using
the AmpliTaq DNA polymerase enzyme
(2.5 units; Perkin-Elmer) and the specific
upstream and downstream primers at a con-
centration of 0.075 pM each. The primers
developed for analysis ofeach ofthe active
MT genes have been previously described
(25). The primers for analysis of MT-2A
mRNA were upper 5'CCGACTCTAGC-
CGCCTCTT3' and lower 5'GTG-
GAAGTCGCGTTCTTTACA3', yielding a
259 bp product. Primers for the determina-
tion ofglyceraldehyde 3-phosphate dehydro-
genase (g3pdh) were obtained commercially
(Clontech, Palo Alto, CA). The thermocy-
cler was programmed to cycle at 95C for a
2-min initial step, at 95C for 15 sec, and at
68C for 30 sec, with a final elongation step
at 68°C for 7 min. Controls for each PCR
included a no-template control in which
water was added instead ofthe RNA and a
no-reverse transcriptase control in which
water was added instead of the enzyme.
Samples were removed at 25, 30, 35, and 40
PCR cycles to ensure that the reaction
remained in thelinear region. Thefinal PCR
products were electrophoresed on 2%
agarose gels containing EtBr along with
DNAmarkers.
Restriction enzymedigestion oftheMT-
2A RT-PCRproduct. Following RT-PCR
(50 pl reaction volume), 25 pl of PCR
product was purified using the QiaQuik
PCR Purification system (Qiagen,
Valencia, CA) according to the manufac-
turer's recommended protocol. DNA was
eluted into 30 pl distilled H20. SgrAI
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Figure 1. Effectofcadmium on human proximaltubule (HPT) cell viability. Confluent
cultures ofthree independent HPTcell isolates (A,B,C)were exposedto 9,27, or45
MM Cd2+for a period of 16 days. Computer-assisted cell counts (nuclei per micro-
scopicfield) wereobtainedfollowing 1,4,7, 10, 13, and 16days ofexposure. Results
are expressed as percentage ofcontrol values. Significantly different*from control,
a =0.000 and **a =0.05;#from 9pM,a =0.000; from 27pM,a = 0.000.
-100 1
* 801
60
1 40 0
X 20
_ 100
c 80
.~ 80
0 ,8; 60
, 40
U
M. 20
0
4 7 10 13 16
Days ofexposure
4 7 10
Days ofexposure
13 16
Volume 106, Number 9, September 1998 * Environmental Health Perspectives
1 Id -
588Articles * MT-2A mRNA expression in metal-treated HPT cells
100
80
60
m100 M M 200 -M M3004M|
4 7 10 13
M50OM m loogm M10
1 4 7 10 13
M50gM m100JAM M200pMh
.5
U
c
16
-5
o
St
16
7 10 13 16
Daysofexposure
restriction digestion ofMT- 2A was carried
out by adding 15 pl DNA, 2 pl NE4
Buffer (New England Biolabs, Beverly,
MA), distilled H20, and 20 units sgrAI
enzyme (New England Biolabs) in a final
reaction volume of 20 pl. Following incu-
bation at 37°C for 1 hr, the reaction was
terminated by adding 5 pl gel-loading
buffer. Samples were electrophoresed on
2% agarose gels containing 0.5X TBE
(0.045 M Tris-borate, 0.001 M EDTA)
and 0.5 pg/ml EtBr.
MTprotein determination. Cells were
washed two times with PBS, harvested in
buffer containing 10 mM Tris (pH 7.4)
and 75 mM NaCl, and lysed byrapid freez-
ing and thawing in liquid nitrogen. Protein
concentration was determined by the BCA
protein assay (Pierce Chemical Co.,
Rockford, IL). For copper-induced samples,
1 mM dithiothreitol was added to the
extract and total protein was determined by
the Bio-Rad protein assay (Bio-Rad
Laboratories, Hercules, CA). MT protein
was detected by immunoblotting using a
mouse anti-horse antibody (DAKO-MT,
E9; Dako, Carpinteria, CA) as the primary
antibody following the procedure outlined
by Mizzen et al. (26). Aliquots of3 pg total
protein were diluted to 75 pl in the above
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Figure 2. Effects of other metals on human proximal tubule (HPT) cell
viability. Confluent cultures of a single HPT cell isolate (Fig. IA) were
exposed to zinc (A), copper (B), silver (C), mercury (D), and lead (E).
Three concentrations of each metal were used, and computer-assist-
ed cell counts (nuclei per microscopic field) were obtained following
1, 4, 7, 10, 13, and 16 days of exposure. Results are expressed as per-
centage of control values. Significantly different *from control, a =
0.000 and **a = 0.05; *from low concentration, a = 0.000 and ##a =
0.05; tfrom medium concentration, a- 0.000 and ta = 0.05.
harvest buffer and mixed with 75 pl of 3%
glutaraldehyde to enhance the detection of
MT. One hundred microliters of this mix-
ture (2 pg total protein) was applied to adot-
blot apparatus with a polyvinylidine difluo-
ride membrane. Samples were allowed to
flow through the apparatus by gravity; this
was followed by two PBS washes. After
blocking with 10% skim milk in PBS, the
membrane was soaked in primary antibody
[1:100 dilution, 1% bovine serum albumin
(BSA) in PBS] for 2 hr. The membrane was
washed three timeswith PBS andanti-mouse
alkaline phosphatase-conjugated secondary
antibody (Promega, Madison, WI) was
added (1:500 dilution, 0.4 % BSA in PBS).
Antibody complexes were visualized using
the alkaline phosphatase kit III (Vector,
Burlingame, CA). Standard curves of rabbit
liver Cd/Zn metallothionein-1 (Sigma, St.
Louis, MO) were applied to each blot. MT
protein was quantified by comparing the
optical density of the dots to the standard
MT curve using image analysis software (KS
400, Kontron). This assay has detection lim-
its in the rangeof0.1-0.5 ng MTprotein.
Results
Effect ofmetal exposure on HPT cell via-
bility. A goal of the present study was to
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Figure 3. Metallothionein (MT) protein expression
as a function of Cd exposure. Protein extracts were
prepared from three independent HPT cell isolates
(A,B,C) at the indicated time points and analyzed
for MT protein by immunoblot. *Significantly differ-
ent from control, a = 0.000; #significantly different
from 9pM concentration, a = 0.000.
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line the pattern of MT protein and were exposed over a 16-day time course to
A mRNA expression in HPT cells three metal concentrations selected to yield
ring exposure to metals, especially patterns ofcell viability ranging from mini-
at both sublethal and lethal concen- mal cell death to a significant loss of cell
is. Confluent cultures of HPT cells viability. Three independently derived
HPT cell isolates were analyzed in the
-- ~ U~ ~A 20 e t CCl2 studies to control for the possibility
of isolate-to-isolate variability. This was
accomplished by exposure of HPT cell
monolayers derived from three indepen-
dent kidney isolates to 9, 27, and 45 pM
concentrations ofCd2+ over a 16-day peri-
od (Fig. 1). For all three HPT cell isolates,
there was minimal cell death for the cells
1 4 7 10 13 16 exposed to the lowest Cd2+ concentration
*Control *-~~250itM A 500MM *750(9 pM), whereas exposure to 45 pM Cd2+
resulted in complete cell death by day 7 of
t exposure. Exposure ofthe HPT cells to 27
_B pM Cd2+ elicited an intermediate pattern
ofcell viabilityfor each isolate.
A single HPT cell isolate, correspond-
.1......._....... ing to the isolate shown in Figure lA, was
studied in detail for the other metals (Fig.
2). A similar pattern of cell viability was
1 4 7 10 13 16 obtained when HPT cells were exposed to
*Control *501M A 100PM * 0>MAg2+ at 50, 100, and 150 pM concentra-
tions. Like the case for Cd2 -exposed cells,
exposure of the HPT cells to the lowest
concentration of Ag2+ had little overall
effect on cell viability, whereas the highest
concentration elicited a complete loss of
cell viability following 10 days ofexposure.
Exposure ofthe HPT cells to the interme-
1 4 7 10 13 16 diate concentration ofAg2+ elicited a mod-
erate loss ofcell viability. Exposure ofHPT
.Contrel *20M A40M *60M cells to the remaining four metal salts,
Zn2+, Cu2+, Hg2+, and Pb2+, also produced
cell viability profiles with dose-response
curves that included the range of minimal
cell death to asignificant loss ofcell viabili-
ty. At each time point in all the above cell
viability studies, triplicate cultures were
processed for the isolation of protein and
1 4 7 10 13 16 total RNA.
---
Control 5iM 200gMEffect ofmetal exposure on the expres-
+Control *5M *A100PlM *200RMI sion ofMTprotein. The level ofMT pro-
tein expression was determined in extracts
of HPT cells prepared at identical time
points and with concentrations of metal
exposures as defined above for the viability
studies. The expression of MT protein was
increased due to Cd2+ exposure in all three
independent HPT cell isolates (Fig. 3). At
1 4 7 10 13 16 the lowest concentration of Cd2+ (9 pM),
Daysofexposure where little loss of cell viability was noted,
4. Metallothionein (MT)protein expression as MT protein accumulation was similar
tion of metal exposure. One human proximal among the three cell isolates. For each iso-
(HPT) cell isolate (Fig. 1A) was exposed to late, MT protein increased in a linear fash-
X), copper (B), silver(C), mercury(D), and lead ion over the initial 7-10 days ofexposure,
the indicated exposure duration and metal reaching a plateau by day 16 of exposure.
.ntrations. MT protein was determined by M a o ... ~~~~~Maximal accumulation of MT protein was loblotSignficantlydifferent*from control, a also similar among the isolates at this level and* a =0.05;#from lowconcentration, a = oCo2+ nd ##a=0.05;tfrom medium concentration, a of Cd exposure: 70, 90, and 110 ng/lsg
) andtta= 0.05. cell protein, respectively. In the isolates
(Fig. 3 A,C) in which the intermediate level
ofCd2+ exposure (27 pM) elicited a gradual
loss of HPT cell viability over time, there
was a dose-dependent increase in MT pro-
tein levels compared to the lower exposure
level, but there was no marked alteration in
the pattern of MT protein accumulation
that would correlate specifically to the loss
ofcell viability. The level ofMT protein at
the highest Cd2+ concentration was only
obtainable following 1 day of exposure due
to cell death, and even at day 1 there was
approximately 50% cell death. While these
samples were analyzed for MT protein, the
large standard errors associated with mea-
surement (the errors were larger than the
measured values) rendered these samples
unsuitable for analysis. Overall, the results
clearly demonstrated that Cd2+ was an
effective inducer of MT protein accumula-
tion in HPT cells well before any loss ofcell
viability was noted to occur.
The expression ofMT protein was also
increased due to exposure ofthe HPT cells
to Zn2+, although the expression pattern
was distinct from that ofCd2P at the lower
levels ofexposure (Fig. 4A). In contrast to
Cd2+-exposed HPT cells, Zn2+-exposed
cells demonstrated only a very modest
induction ofMT protein when exposed to
the low and intermediate concentrations
(100 and 200 pM) ofZn2+ that elicited no
marked reductions in HPT cell viability.
However, at the highest concentration of
Zn2+ exposure, where cell death was noted
to occur late in the time course, the levels
of MT protein were markedly induced,
compared to both the lower concentrations
and the control. Furthermore, the level of
induction was comparable to that noted for
HPT cells exposed to Cd2P. The expression
of MT protein was also increased due to
exposure ofthe HPT cells to toxic concen-
trations ofCu2+ (Fig. 4B). The increase in
MT protein accumulation was both dosage
dependent and comparable in magnitude
to that noted previously for the Cd2+- and
Zn2 -exposed cells. Similar to Zn2+
exposed HPT cells, MT protein accumula-
tion was also blunted at the lowest level of
Cu2+ exposure when compared to the
increase obtained forCd2+-exposed cells.
In marked contrast to the large induc-
tion of MT protein accumulation found
for HPT cells exposed to Cd2+, Zn2+, or
Cu2+, the expression of MT protein was
only marginally increased, if at all, when
the HPT cells were exposed to sublethal or
lethal concentrations ofAg2+, Hg2+, or
Pb2+ (Fig. 4C,D,E). For HPT cells exposed
to Ag2+, there was no increase in MT pro-
tein at the lowest level ofexposure and only
a very modest increase at the intermediate
level of exposure, an exposure level where
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loss of cell viability occurred late in the
time course. The increase in MT protein in
cells exposed to Ag2+ was less than 5% of
that found for Cd +- exposed cells at simi-
lar time points and toxicities. For HPT
cells exposed to Hg2+ (Fig. 4D), there was
also only a very modest induction of MT
protein compared to cells exposed to Cd +
Zn2+, or Cu2+ at similar time points and
toxicities. The very small increase in MT
protein that did occur was not dosage
dependent and the expression pattern
demonstrated no obvious relationship to
the loss of cell viability. For HPT cells
exposed to Pb2+, there was no increase in
MT protein regardless of exposure level or
loss ofcell viability (Fig. 4E).
Determination ofMT-2A mRNA.
Accumulation ofMT-2AmRNAwas deter-
mined using an RT-PCR strategy based on
the sequence diversity present in the 5' and
3' untranslated regions of the active MT
genes (25). This strategy was chosen over
Northern analysis due to the high degree of
sequence homology among the active MT
genes. This high degree ofsimilarity among
the nucleotide sequences of the 10 active
MT genes makes it difficult to confirm ifan
individual probe for Northern analysis is
specific for measuring a given individual
MT isoform. The advantage of the RT-
PCR strategy is that the resultant PCR
product itselfcan be analyzed to determine
ifthe primer pairs chosen for analysis were
indeed specific for the MT-2A mRNA.
This was accomplished in the present study
by determining the profile of restriction
endonuclease cutting sites for all 10 active
MT gene sequences and identifying a
restriction site present only in the MT-2A
sequence. For the MT-2A gene, a unique
restriction site was identified as an sgrAI site
(CR/CCGGYG) that would hypothetically
cleave the 259 bp MT-2A RT-PCR prod-
uct into two fragments (51 bp and 208 bp)
ifthe reaction was specific for mRNA from
the MT-2A gene. Using the noted MT-2A
primers, this was tested on the RT-PCR
products ofthe reaction initiated with 100
ng of total RNA obtained from normal
human kidney tissue, from control HPT
cells, and from HPT cells treated 24 hrwith
45 jiM Cd2+ (Fig. 5). It was demonstrated
that each RNA source resulted in reaction
products that were cleaved by the sgrAI
restriction endonuclease into fragments of
approximately 200 bp and a smaller frag-
ment of approximately 50 bp, consistent
with cleavage of the 259-bp MT-2A reac-
tion product into 208- and 51-bp products
as predicted by sequence information. In all
cases, sgrAI digestion resulted in the com-
plete disappearance of the 259-bp reaction
product, indicating that the reaction prod-
uct was composed entirely of the MT-2A
sequence and not partially contaminated
with a product generated by false priming.
The negative control (MT-3 cDNA), which
has no sgrAl restriction site, was obtained
from a previous study in which RT-PCR
primers for MT-3 were shown to yield a
legitimate MT-3 cDNA reaction product
by a combination of both restriction
endonuclease digestion by FokI and direct
sequencing (27-).
Evpression ofMT-2A mRNbA as afunc-
tion ofmetalexposure. The level ofMT-2A
mRNAexpression was determined on 0.1 pg
400 bp
300 bp
200 bp
100 bp
75 bp
50bp
25bp
Figure 5. SgrAl cleavage of MT-2A RT-PCR prod-
ucts from total RNA derived from human kidney
tissue and cultured human proximal tubule (HPT)
cells. Lanes 1 and 10 are base pair ladders; Lane
2, undigested product, kidney tissue; Lane 3,
digested product, kidney tissue; Lane 4, undigest-
ed product, HPT cells; Lane 5, digested product,
HPT cells; Lane 6, undigested product, Cd-treated
(16 days at 27 pM Cd) HPT cells; Lane 7, digested
product, Cd-treated HPT cells; Lane 8, undigested
RT-PCR product for MT-3, HPT cells; Lane 9,
digested RT-PCR productfor MT-3, HPT cells.
2 p 25Cycles 11 30Cycles ---
Figure 6. Evaluation of RT-PCR cycles for MT-2A
mRNA. RT-PCR for MT-2A was performed on
control RNA from three human proximal tubule
(HPT) cell isolates (A,B,C) and sampled at vari-
ous cycle numbers. Reaction products were
electrophoresed on 2% agarose gels containing
0.5 pg/mI ethidium bromide. Integrated optical
density (IOD) values [OD (inverted) x pix-
els2/1000] for individual bands are shown for A.
a | 25 Cycles - 30 Cycles
1 A 7 in 11 1r 1 A 7 in 11 1r
Et 7
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Figure 7. Expression of MT-2A mRNA in human proximal tubule (HPT) cells exposed to cadmium. RT-PCR
for MT-2A and glyceraldehyde 3-phosphate dehydrogenase (G3PDH) was performed on three HPT cell
isolates (A,B,C). Relative integrated optical density values 1OD (inverted) x pixels2/10001 are shown for
each isolate in the upper panel. The IOD value for each dose and time point was divided by the corre-
sponding glyceraldehyde 3-phosphate dehydrogenase IOD value.
of total RNA isolated from HPT cells at
identical time points and concentrations of
metal exposures, as described above in the
viability and MT protein expression studies.
To ensure that MT-2A mRNA expression
was determined in the linear region of the
RT-PCR, reactions were stopped and sam-
ples removed for analysis at various time
points. The need toanalyzecomparative RT-
PCR in linear regions ofthe reaction cyde is
illustrated effectively bythe determination of
MT-2A mRNA expression in control HPT
cells unexposed to metals (Fig. 6). For the
initial cell isolate used in this study, analysis
ofMT-2A mRNA was determined following
25, 30, and 35 PCR cydes primed with 0.1
pg of control total RNA samples obtained
from HPT cells over the 16-day time course.
Both visual analysis and integrated optical
density measurements ofthe RT-PCR prod-
uct intensities at 25, 30, and 35 reaction
cycles clearly demonstrated that the PCR
had reached saturation between cycles 30
and 35; indicating that results at these cydes
would be unsuitable for comparative analysis
(Fig. 6A). In contrast, the reaction product
bands at cyde 30 indicate that the reaction is
in thelinear region andwouldbesuitable for
usein comparative RT-PCR It was also con-
firmed for the other two HPT cell isolates
that the PCRproduct at 30 cydes was in the
linear rangeofthe reaction (Fig. 6B,C).
The effect of Cd2+ exposure on the
expression of MT-2A mRNA was also
determined at 30 reaction cycles using 0.1
pg of total RNA from the three indepen-
dent isolates of HPT cells. A comparative
analysis demonstrated that expression of
MT-2A mRNA did not appear to increase
beyond control levels in any of the three
independent isolates of HPT cells regard-
less of Cd2+ concentration, time of expo-
sure to Cd2P, or whether there was a CP-
induced loss of cell viability (Fig. 7). The
failure of metal treatment to elicit a large
increase in the accumulation of MT-2A
mRNA was also confirmed for HPT cells
exposed to Zn2+, Cu2+, Ag2+, Hg2+, and
Pb2+ (Fig. 8). Similar to the case for Cd2P-
exposed cells, MT-2A mRNA levels were
not increased over control by the other
metals regardless of concentration, dura-
tion of exposure, or whether a given metal
exposure resulted in loss ofcellviability.
Because the finding that MT-2A
mRNA was not increased in the metal-
treated HPT cells was unexpected, a con-
trol was sought to validate the RT-PCR
procedure. The HepG2 cell line was cho-
sen because exposure to Cd2P and Zn2+ has
been shown to result in 10- to 20-fold ele-
vations of MT-2A mRNA (22). HepG2
cells were grown to confluencyandexposed
to 9 pM Cd2P or 100 pM Zn2+, and total
RNA was isolated following 8 and 24 hr of
exposure. The results ofthis determination,
using an input of 0.1 pg total RNA for
RT-PCR, clearly demonstrated that both
Cd2+ and Zn2+ were effective inducers of
MT-2A mRNA expression (Fig. 9).
Control cells demonstrated a reaction
product for MT-2A mRNA beginning at
26 reaction cycles. Both the Cd2+- and
Zn2+-exposed cells demonstrated MT-2A
reaction products beginning at 20 reaction
cycles. These findings effectively demon-
strate that the RT-PCR method used to
determine MT-2A mRNA is valid and can
detect an increase in MT-2A mRNA. A
similar induction of MT-2A mRNA has
also been reported for Hela cells (22). Hela
cell MT-2A induction was also confirmed
using the RT-PCR assay for MT-2A
mRNA (data not shown).
Discussion
Many of the major features of renal MT
protein expression expected from the accu-
mulated knowledge gained from rodent
animal models were demonstrated in cul-
tures ofHPT cells exposed to various met-
als. When differences were noted in the
induction of MT protein expression
between the cultured cells and the rodent
animal models, these proved to be areas in
which there was a limited database of
rodent-based studies. In these instances,
the results with cultured cells can be looked
upon as extensions of the overall knowl-
edge base ofthe renal effects ofeach given
metal rather than defining large discrepan-
cies between humans and animal models. A
major shared feature of the rodent and
human renal systems was clearly demon-
strated in the capacity for Cd2+ exposure to
induce alarge increase in MT proteinwith-
in the renal proximal tubule. In general, it
has been shown in numerous rodent stud-
ies that Cd2+ is a potent inducer of the
hepatic and renal MT-1 and MT-2 genes,
which leads to large increases in MT pro-
tein accumulation (1,28-30). In the pre-
sent study, exposure of HPT cells to both
lethal and sublethal Cd2+ concentrations
elicited greater than 20-fold accumulations
ofMT protein in adose-dependent fashion
over the time course. In accordwith rodent
animal models, we demonstrated that Cd2+
was the strongest inducer of MT protein
expression in HPT cells at concentrations
below those eliciting cell death. In whole
animals, Cd2+ has been shown to be the
strongest inducer of the metallothionein
genes and protein, followed by Zn2+, Ag2+,
Hg2+, Bi2+, andCu2+, withNi2W, Ca2+, and
Pb2+ being poor inducers (30). Thus, the
pattern ofMT protein expression for HPT
cells exposed to Cd2+ was very similar to
thatexpectedfrom animal model studies.
The demonstration that HPT cells
accumulated MT protein when exposed to
Zn2+ is also in agreement with studies in
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Figure 8. MT-2A mRNA expression following
exposure to Zn (A), Cu (B), Ag (C), Hg (D), and Pb
(E). RT-PCR for MT-2A was performed on total
RNA from one HPT cell isolate (Fig. 1A) exposed
to various metal concentrations over a 16-day
time course, and reaction products are shown for
days 1, 4, 7, 10, 13, and 16. Relative integrated
optical density values [OD (inverted) x pix-
els2/1000] are shown for each metal exposure.
The IOD value for each dose and time point was
divided by the corresponding glyceraldehyde 3-
phosphate dehydrogenase IOD value.
rodent models and derived cell cultures
(1,2,28,29). The present studies with HPT
cells also extended this observation. In HPT
cells exposed to Zn2+, we have shown that
the degree ofMT protein accumulation was
influenced by the level of metal exposure.
While the MT protein content of HPT
cells was elevated significantly above control
at Zn2+ concentrations eliciting little or no
cell death, this level of induction was only
modest when compared to the MT protein
levels obtained when the cells were exposed
to Cd2+ at nonlethal concentrations. In
contrast, when HPT cells were exposed to
Zn2+ at concentrations that elicited cell
death late in the time course, the increase in
MT accumulation was equal to or greater
than that found for HPT cells exposed to
Cd2+. These findings are of interest in the
human renal system because one of the
functions ascribed to MT is to buffer intra-
cellular Zn2+ concentrations and thereby
attenuate toxicity and deficiency (31).
Further evidence for this concept has come
from recent studies with transgenic mice
demonstrating that MT-1 and MT-2 pro-
tect against zinc deficiency and toxicity and
that mice which overexpress MT are resis-
tant to dietary zincdeficiency (32,33).
Although fewer studies document the
ability ofCu2+ to induce MT in the rodent
renal system, existing studies demonstrate
the induction ofMT protein accumulation
by Cu2+, although at levels 100% less effec-
tive than Zn2+ (34,35). As such, the finding
that HPT cells accumulate MT protein as a
result of Cu2+ exposure is consistent with
current animal model studies. However, as
noted for Zn2+-exposed HPT cells, the cur-
rent studies also demonstrated that the
degree of MT protein accumulation by
HPT cells exposed to Cu2+ was clearly
influenced by metal exposure levels, either
at lethal or sublethal concentrations. The
accumulation of MT protein by Cu2+-
exposed cells was highest at concentrations
that elicited cell death. Cu2+-exposed HPT
cells were also shown to accumulate similar
quantities of MT protein as Cd2+- and
Zn2+-exposed cells. The current findings in
HPT cells suggest that the human proximal
tubule is capable ofa significant increase in
the accumulation ofMT protein as Zn2+ or
Cu2+ reach levels eliciting cell death.
There were also some differences
between animal model data and the HPT
cells that involved an inability ofHPT cells
to accumulate MT protein upon metal
exposure. Most striking was the marginal
induction of MT protein accumulation
when HPT cells were exposed to Hg2 .
Several studies have shown that treatment
ofrats with either asingle dose or repeated
doses of inorganic Hg + causes the renal
concentration of MT to increase (36-38).
This increase occurs particularly in the
outer cortex and outer stripe of the outer
medulla and is presumably due to increased
transcription ofthe MT genes (3,9). In con-
trast, an increase ofthis magnitude was not
noted for HPT cells exposed to Hg2+ at
either lethal or sublethal levels. A lack of
induction of MT protein was also noted
when the HPT cells were exposed to Ag2+
at both lethal and sublethal concentrations.
Even though silver is classified as having
minor toxicity, these findings are ofinterest
because the intentional use ofsilver in med-
ical and dental products increases potential
exposure (40). However, the results regard-
ing Ag2+ exposure are difficult to interpret,
as there is only a very limited literature base
detailing the response to Ag+ exposure in
general, and the MT response in particular,
for both animals and humans (41,42). The
present studies using HPT cells demon-
strate that both Hg2+ and Ag2+ elicit only
marginal, ifany, MT protein accumulation.
The exposure ofHPT cells to Pb2+ was
designed to serve as a negative control for
MT protein induction since exposure to
Cycle
20
22
24
26
28
30
4;X~ X (~~~S ~~ d"~~~' &'~t
Figure 9. MT-2A mRNA expression in HepG2 cells
following exposure to zinc or cadmium. RT-PCR
for MT-2A was performed on RNA from cultured
HepG2 cells exposed to zinc (100 pM) or cadmium
(9 pM). RT-PCR products were sampled at 20, 22,
24, 26, 28, and 30 cycles. Products are shown for
control cultures and cultures following 8 and 24 hr
of metal exposure.
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Pb2+ has been reported to induce hepatic
but not renal MT in animals (34,43-47).
The findings with HPT cells were in agree-
ment because no concentration of Pb2+,
lethal or sublethal, was noted to increase
MT accumulation. Ifone ranks the ability
ofthe metals to induce the accumulation of
MT protein in HPT cells at exposure levels
near lethal conditions, Cd2 , Zn2+, and
Cu2+ are potent inducers with very similar
efficiencies, while Hg2+, Ag2+, and Pb2+
demonstrate little, ifany, significant induc-
tion ofMT protein accumulation.
Even though the results regarding MT
protein accumulation by HPT cells exposed
to metals were similar to those noted in ani-
mal models, the regulation of the MT-2A
gene in HPT cells appears unique compared
both to animal models and to other human
systems. In rodents, overwhelming evidence
suggests that the hepatic and renal MT-1
and MT-2 genes are widely expressed and
co-regulated by many agents including met-
als, hormones, and xenobiotics (2,11). We
could find no instances in the literature of
studies using rodent models or rodent tissue-
derived cell cultures in which renal and
hepatic MT-2 mRNA has not been demon-
strated to be induced upon exposure to Zn2+
or Cd2P. This also appears to be true in the
human system, although for obvious reasons
the induction ofMT-2A mRNA via metals
has been tested onlyundercell culture condi-
tions. The initial observation of the induc-
tion of the human MT-2A gene by metals
demonstrated that in 15 human-derived cell
cultures, Cd2+ treatment resulted in a 10- to
30-fold induction of MT-2A mRNA (22).
Induction ofMT-2A mRNA by Cd2P treat-
ment has also been demonstrated for lym-
phoid-derived cell lines (48). The potential
significance ofthe expression and induction
ofMT-2A mRNA in the human is under-
scored by the observation that the ability to
induce expression ofMT-2A mRNA corre-
lates with development ofcisplatin resistance
in three human squamous cell carcinoma cell
lines (49). In this study, the pattern ofgene
expression was determined for the MT-2A,
MT-lA, B, E, F, and G genes in three pairs
of cell lines in which one member of each
pairwas resistant to cisplatin. Yang et al. (49)
found that MT-2A mRNAwas inducible by
zinc, that the most highly overexpressed MT
isoform in all three cisplatin resistant human
carcinoma cell pairs was MT-2A, and that
no other isoform was universally overex-
pressed. This finding was interpreted as
being consistent with a role for the MT-2A
isoform in mediating cisplatin resistance. To
our knowledge, the finding that MT-2A
mRNA accumulation was not increased by
Cd2+ exposure in HPT cells is the first
demonstration that the human MT-2A gene
can be refractory to heavy metal treatment.
Proofthat RT-PCR was specific for MT-2A
mRNA and that increased accumulation
could be detected was provided by two pro-
cedures. First, an advantage provided byRT-
PCR is the ability to recover the reaction
product from the agarose gel and to subject
this product to further analysis to confirm
identityofagiven gene. In the present study,
this advantage was used to determine that
the MT-2A RT-PCR product contained a
sgrAl restriction endonuclease cleavage site, a
site known from sequencing data to be pre-
sent only in the MT-2A gene ofthe human
MT family. The demonstration that sgrAl
digestion completely cleaved the MT-2A
reaction product into appropriate fragments
provides a high degree ofconfidence that the
primers developed for MT-2A mRNA and
the RT-PCR were specific for the transcrip-
tion product ofthe MT-2A gene. Proofthat
the RT-PCR protocol could detect an
increased accumulation of MT-2A mRNA
relied on previous studies which demonstrat-
ed that the HepG2 cell line, when exposed
to either Cd2+ or Zn2+, displayed a 10- to
20-fold accumulation of MT-2A mRNA
(22). Utilizing the HepG2 cell line and
exposures to Cd2+ and Zn2+, the RT-PCR
protocol that we used demonstrated a large
increase in the amount ofaccumulated MT-
2AmRNAfortreatedversus control cells.
The present study demonstrates strong
similarities between the human and rodent
renal system in the ability to accumulate
MT protein as a result of metal exposure.
However, the studies also provide initial
evidence that this accumulation of MT
protein may be mediated through distinctly
different patterns of gene regulation
between humans and animals.
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